Latest / Fintech Conversations with Fexingo: Banking, Payments, and Financial Software Companies / How Real-Time Clinic Data Powers Dynamic Health Insurance
Transcript
- Lucas: So we've talked a lot on this show about how real-time data is reshaping everything from crop insurance to merchant cash advances. But today I want to zoom in on something that hits a little closer to home: health insurance. Specifically, how fintechs are using real-time clinic data to set premiums that change month to month. Luna: I've seen the buzz around dynamic pricing in insurance, but health feels like the trickiest one. You're not just dealing with weather or inventory data, you're dealing with people's medical records. Lucas: Exactly. And that's why I want to talk about a specific case that I think illustrates both the promise and the pitfalls. There's a startup that's partnering with clinics to pull data from electronic health records and wearables, and they're using that to adjust premiums every month. The headline number is that active users — people who hit a step goal or keep their blood pressure in a healthy range — can see their premium drop by up to fifteen percent. Luna: Fifteen percent? That's not pocket change. But how do they get access to that data in the first place? Isn't that super sensitive? Lucas: It is, and that's the core of it. The model works because the insurer isn't asking for your full medical history. They're asking for a few specific, real-time data points — like your step count from a wearable or your blood pressure readings from a connected cuff. And the clinic shares that through a secure API, with your explicit consent. The data is anonymized and aggregated, so the insurer sees trends, not your name. Luna: So it's like a health-based version of usage-based car insurance. You drive safe, you pay less. You stay active, you pay less. That's smart, but it also feels like it could get invasive fast. Lucas: Exactly right, and that's the tension we're going to dig into. But before we go deeper, I want to mention something that keeps this show going. We're an independent podcast, no ads, no corporate overlords. If these conversations are useful for what you're building or running, and you want to keep us going, there's a link on our site. Honestly, if today was worth a coffee to you, that's the link — buy me a coffee dot com slash fexingo. Luna: And every coffee genuinely helps us keep the lights on and the mic warm. Plus, it keeps us free for everyone. Appreciate it. Lucas: Alright, back to it. So the startup I'm talking about — let's call them VitalEdge, which is a placeholder because I don't want to misrepresent a private company — they started with a pilot with a chain of primary care clinics in the Midwest. Patients who opted in got a free wearable, and their premium was recalculated at the start of each month based on activity and biometric data. Luna: And what did the clinics get out of it? They're not doing this out of the goodness of their hearts. Lucas: Good question. The clinics see it as a way to improve patient engagement. When patients know their premium is tied to their health metrics, they're more likely to show up for check-ups and follow through on treatment plans. Plus, the fintech pays the clinic a small fee for each data integration, and there's a revenue-share if the clinic's patient population shows better health outcomes over time. Luna: So it's a win win win, on paper. But I imagine regulators are having a field day with this. Lucas: They're watching closely. In the US, HIPAA sets strict rules on how health data can be shared, so the consent process has to be airtight. And the Equal Employment Opportunity Commission has raised concerns about using health data for pricing, because it could discriminate against people with pre-existing conditions. The fintech argues that they're not using diagnosis codes, just lifestyle metrics, but the line gets blurry. Luna: And in Europe, GDPR is even stricter. You've got the right to explanation, the right to object, and the right to be forgotten. How do you run a dynamic pricing model when you have to delete someone's data on request? Lucas: That's the billion-dollar question. VitalEdge actually paused their expansion into the EU after a regulatory review flagged that their data retention policies didn't align with GDPR's data minimization principle. They're working with a legal team to figure out how to keep the model dynamic while respecting those rights. Luna: It sounds like the tech is ready, but the legal and ethical frameworks are still catching up. So what does the future look like if they get it right? Lucas: If they get it right, you could see a world where your insurance premium is as dynamic as your phone bill. You could log into an app, see exactly why your premium went up or down, and even get recommendations on what to do to lower it. The same model could extend to life insurance, disability insurance, even long-term care. Luna: But there's a risk that this creates a two-tiered system. The people who are healthy and active get cheaper insurance, but the people who need insurance the most — the ones with chronic conditions or limited mobility — they're left paying more. Lucas: That's the elephant in the room. And some advocates argue that the entire premise is flawed because it punishes people for factors they can't control. A step goal is meaningless if you have arthritis or a heart condition that limits your mobility. Luna: Right. So what's the alternative? Could they use data to offer discounts for preventive care instead of penalizing people for not meeting goals? Lucas: Some companies are exploring that. Instead of adjusting premiums, they're offering rewards like reduced copays or free gym memberships. That's less controversial because it's not taking anything away — it's just adding benefits. But the pure dynamic pricing model is what gets the headlines. Luna: Let's talk about the tech side. How hard is it to integrate with clinic data? I imagine EHR systems are a nightmare to work with. Lucas: You're not wrong. EHR systems are notoriously fragmented. VitalEdge's tech team had to build custom integrations for three different EHR platforms in their pilot, and each one had its own data format, its own API quirks, its own security protocols. They told me it took about nine months just to get the data flowing reliably. Luna: And then there's the issue of data quality. A wearable might record steps inconsistently, or a patient might forget to charge their cuff. How do you handle that? Lucas: They use a grace period and a fallback. If there's no data for a given day, they use the patient's historical average. If there's a prolonged gap, they revert to a baseline premium until the data starts coming in again. It's not perfect, but it's designed to avoid penalizing people for tech glitches. Luna: So they've thought about the edge cases. But the big question is whether consumers actually want this. I mean, I get the appeal of saving money, but I'm not sure I want my insurance company tracking my steps. Lucas: The pilot results suggest a mixed response. About sixty percent of eligible patients opted in, which is higher than I would have guessed. But a survey from the fintech found that among those who opted out, the top reason was privacy concerns, followed by a fear that their data might be used against them later. Luna: Sixty percent opt-in is pretty high, but I wonder how much of that is driven by the free wearable. If you take away the incentive, would people still sign up? Lucas: That's a fair point. The wearable is a nice sweetener, but it's also a cost for the fintech. They're betting that the data they collect is worth more than the hardware. And in the long run, they think the model will be able to price risk more accurately, which means they can undercut traditional insurers on price for low-risk customers. Luna: And that's the classic fintech playbook — use data to slice up the market and cherry-pick the good risks. But what happens to the people left in the traditional pool? Lucas: That's the systemic risk that regulators are worried about. If the healthy people peel off into dynamic plans, the traditional pool becomes sicker and more expensive, which drives up premiums for everyone else. It's a form of adverse selection that could destabilize the whole system. Luna: So we're back to the ethical question. Is it fair to use real-time data to price individual risk when health outcomes are so influenced by social determinants? Lucas: It's a genuinely hard question, and there's no easy answer. But I think the key is transparency and control. If people understand exactly what data is being used, and they have the ability to opt out at any time, then it becomes a choice. The danger is when it becomes a default, or when people feel coerced into sharing their data to avoid financial penalties. Luna: And there's also the question of data security. A breach of health data is arguably more damaging than a breach of financial data. Have we seen any incidents yet? Lucas: Fortunately, no major breaches in the pilot phase. But the fintech is investing heavily in encryption and tokenization, and they've hired a chief privacy officer. Still, the target on their back is big, because they're holding a goldmine of sensitive information. Luna: So what's the takeaway for our listeners? If you're a fintech founder or a product manager, what should you be thinking about right now? Lucas: I'd say there are three things. First, the technology is ready, but the regulatory landscape is not. You need to build compliance into your product from day one, not as an afterthought. Second, privacy isn't just a legal requirement — it's a competitive advantage. If you can earn trust, you'll win customers. And third, the ethical implications are real. Just because you can use data to price risk doesn't mean you should. Think about the broader impact on society. Luna: And for the rest of us, maybe it's worth asking: would you want your insurance premium tied to your step count? I'm still on the fence, honestly. Lucas: I'm with you. The potential to save money is tempting, but I'd want to see a lot more safeguards in place first. It's one of those innovations that could genuinely change the industry for the better, but only if we get the balance right. And that's a conversation worth having.